Literature DB >> 6929221

Nonspecific cross-reacting antigen in normal and leukemic myeloid cells and serum of leukemic patients.

B Wahren, G Gahrton, S Hammarström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6929221

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

1.  Expression of pregnancy-specific beta 1-glycoprotein genes in hematopoietic cells.

Authors:  S M Wu; L S Bazar; M L Cohn; R A Cahill; W Y Chan
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

Review 2.  Recent advances in bone marrow scanning.

Authors:  S N Reske
Journal:  Eur J Nucl Med       Date:  1991

3.  Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging.

Authors:  Gianmario Sambuceti; Massimo Brignone; Cecilia Marini; Michela Massollo; Francesco Fiz; Silvia Morbelli; Ambra Buschiazzo; Cristina Campi; Roberta Piva; Anna Maria Massone; Michele Piana; Francesco Frassoni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-26       Impact factor: 9.236

4.  Demonstration of carcinoembryonic antigen in bone marrow from patients with carcinoma.

Authors:  A Gray; R Downing; R Hill; R W Payne; C W Windsor
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

5.  Technetium-99m scintigraphy: more accurate assessment of ulcerative colitis with exametazime-labelled leucocytes than with antigranulocyte antibodies.

Authors:  S Almers; G Granerus; L Franzén; M Ström
Journal:  Eur J Nucl Med       Date:  1996-03

6.  Serum NCA in bone marrow transplant recipients and its metabolism.

Authors:  F Gadler; B Wahren
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

7.  Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution. Technical note.

Authors:  S N Reske; U Buell
Journal:  Eur J Nucl Med       Date:  1990

Review 8.  Radionuclide imaging of bone marrow disorders.

Authors:  Ali Agool; Andor W J M Glaudemans; Hendrikus H Boersma; Rudi A J O Dierckx; Edo Vellenga; Riemer H J A Slart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

9.  Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.

Authors:  A Noworolska; A Harłozińska; R Richter; W Brodzka
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

10.  An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia.

Authors:  N Frénoy; M Ben-Bunant; C Berruel; J A Child; M C Gendron; J L Missett; E Razafimahaleo; P Burtin
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.